NBIX
NASDAQ
US
Neurocrine Biosciences, Inc. - Common Stock
$131.60
▼ $-0.96
(-0.72%)
Vol 707K
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$14.1B
P/E
33.0
ROE
15.8%
Margin
16.0%
D/E
0.00
Beta
0.31
52W
$84–$160
Wall Street Consensus
36 analysts · Apr 202613
Strong Buy
18
Buy
5
Hold
0
Sell
0
Strong Sell
86.1%
Buy Rating
Price Chart
Similar Stocks
RVMD
Revolution Medicines Inc
$15.4B
MRNA
Moderna Inc
$11.5B
INCY
Incyte Corp
P/E 16.3
$19.4B
SMMT
Summit Therapeutics Inc
$13.0B
BBIO
BridgeBio Pharma Inc
$14.7B
MDGL
Madrigal Pharmaceuticals Inc
$13.2B
IONS
Ionis Pharmaceuticals Inc
$12.8B
EXEL
Exelixis Inc
P/E 17.3
$11.8B
BMRN
BioMarin Pharmaceutical Inc
P/E 21.9
$11.4B
PRAX
Praxis Precision Medicines Inc
$7.4B
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $1.92 | $1.48 | $-0.44 |
| Sep 2025 | $1.62 | $2.04 | +$0.42 |
| Jun 2025 | $0.99 | $1.06 | +$0.07 |
| Mar 2025 | $0.56 | $0.08 | $-0.48 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 13.2% | 13.2% | 13.2% | 15.8% | 15.8% | 15.8% |
| P/E (TTM) | 35.71 | 37.70 | 39.76 | 33.36 | 35.38 | 33.04 |
| Net Margin | 15.6% | 13.9% | 13.9% | 15.9% | 15.9% | 15.9% |
| Gross Margin | 98.4% | 98.5% | 98.5% | 98.4% | 98.4% | 98.4% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.20 | 3.20 | 3.20 | 3.38 | 3.38 | 3.38 |
Key Ratios
ROA (TTM)
11.0%
P/S (TTM)
5.27
P/B
5.3
EPS (TTM)
$4.19
CF/Share
$2.11
Rev Growth 3Y
+27.6%
52W High
$160.18
52W Low
$84.23
$84.23
52-Week Range
$160.18
How does NBIX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
NBIX valuation vs Biotechnology peers
P/E ratio
33.0
▲
76%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
5.3
▼
59%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
5.3
▲
117%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
NBIX profitability vs Biotechnology peers
ROE
15.8%
▲
124%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
16.0%
▲
106%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
98.4%
▲
25%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
11.0%
▲
124%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
NBIX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.4
▼
24%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼
68%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
NBIX fundamentals radar
NBIX
Peer median
Industry
NBIX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NBIX vs peers: key metrics
Related Signals
Latest News
No related news yet